First‐in‐human clinical trial of allogeneic, platelet‐derived extracellular vesicles as a potential therapeutic for delayed wound healing

111 indexed citations

Abstract

loading...

About

This paper, published in 2023, received 111 indexed citations. Written by Mozhgan Shojaee, Anabel Silva, Anna Cifuentes‐Rius, Patrick F. James, Angus M. Tester, Ian Dixon and Gregor F. Lichtfuss covering the research area of Molecular Biology, Rehabilitation and Urology. It is primarily cited by scholars working on Molecular Biology (87 citations), Cancer Research (27 citations) and Rehabilitation (26 citations). Published in Journal of Extracellular Vesicles.

Countries where authors are citing First‐in‐human clinical trial of allogeneic, platelet‐derived extracellular vesicles as a potential therapeutic for delayed wound healing

Specialization
Citations

This map shows the geographic impact of First‐in‐human clinical trial of allogeneic, platelet‐derived extracellular vesicles as a potential therapeutic for delayed wound healing. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by First‐in‐human clinical trial of allogeneic, platelet‐derived extracellular vesicles as a potential therapeutic for delayed wound healing with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites First‐in‐human clinical trial of allogeneic, platelet‐derived extracellular vesicles as a potential therapeutic for delayed wound healing more than expected).

Fields of papers citing First‐in‐human clinical trial of allogeneic, platelet‐derived extracellular vesicles as a potential therapeutic for delayed wound healing

Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of First‐in‐human clinical trial of allogeneic, platelet‐derived extracellular vesicles as a potential therapeutic for delayed wound healing. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the First‐in‐human clinical trial of allogeneic, platelet‐derived extracellular vesicles as a potential therapeutic for delayed wound healing.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

This paper is also available at doi.org/10.1002/jev2.12332.

Explore hit-papers with similar magnitude of impact

Rankless by CCL
2026